SCHEMBL16569876

SCHEMBL16569876

CC(C)c1cc(-c2nnc(O)n2-c2ccc(CN3CCN(S(=O)(=O)N4CCC(C(=O)N5CCC(C(=O)O)CC5)CC4)CC3)cc2)c(O)cc1O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ LMNA P02545 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.38
▸ HSP90AA1 P07900 6/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16569373 0.95 HSP90AA1 (0.41) ALDH1A1CYP2C19HSP90AA1
SCHEMBL16569200 0.92 KDM4E (0.42) ALDH1A1TSHRKMT2AHSP90AA1L3MBTL1
SCHEMBL16569651 0.88 HSP90AA1 (0.44) KMT2AHSP90AA1
SCHEMBL24321350 0.86 MEN1 (0.47) ALDH1A1TSHRKMT2AHSP90AA1L3MBTL1
SCHEMBL18561685 0.85 HSP90AA1 (0.40) ALDH1A1TSHRKMT2AHSP90AA1L3MBTL1
SCHEMBL24321184 0.85 HSP90AA1 (0.46) ALDH1A1TSHRKMT2AHSP90AA1L3MBTL1
SCHEMBL17293918 0.85 L3MBTL1 (0.40) ALDH1A1TSHRKMT2AHSP90AA1L3MBTL1
SCHEMBL24321134 0.84 HSP90AA1 (0.47) ALDH1A1TSHRKMT2AHSP90AA1L3MBTL1
SCHEMBL24321700 0.84 HSP90AA1 (0.44) ALDH1A1HSP90AA1
SCHEMBL23135232 0.83 HSP90AA1 (0.41) HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035938-A1 TARGETED THERAPEUTICS Synta Pharmaceuticals Corp. (US) 2016-06-29 — — EP disclosed
WO-2015038649-A1 TARGETED THERAPEUTICS SYNTA PHARMACEUTICALS CORP. (US) 2015-03-19 — — WO disclosed
Send feedback